The Prognostic Significance of the Depth of Cervical Stromal Invasion in Women With FIGO Stage II Uterine Endometrioid Carcinoma

被引:3
|
作者
Al Khatib, Sondos [1 ]
Bhatnagar, Aseem [1 ]
Elshaikh, Noor [1 ]
Ghanem, Ahmed I. [1 ,5 ]
Burmeister, Charlotte [2 ]
Allo, Ghassan [3 ]
Alkamachi, Bassam [3 ]
Paridon, Alex [4 ]
Elshaikh, Mohamed A. [1 ]
机构
[1] Henry Ford Canc Inst, Dept Radiat Oncol, 2800 W Grand Blvd, Detroit, MI 48202 USA
[2] Henry Ford Canc Inst, Dept Publ Hlth, Detroit, MI 48202 USA
[3] Henry Ford Canc Inst, Dept Pathol, Detroit, MI 48202 USA
[4] Henry Ford Canc Inst, Dept Womens Hlth Serv, Div Gynecol Oncol, Detroit, MI 48202 USA
[5] Alexandria Univ, Alexandria Clin Oncol Dept, Fac Med, Alexandria, Egypt
来源
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 2023年 / 46卷 / 10期
关键词
endometrial carcinoma; stage II; cervical stromal invasion; adjuvant; hysterectomy; prognosis; CANCER; RECURRENCE; SURVIVAL; BRACHYTHERAPY; RADIOTHERAPY; INTERVAL;
D O I
10.1097/COC.0000000000001033
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The objective of this study was to investigate the prognostic significance of the depth of cervical stromal invasion (CSI) in women with FIGO stage II uterine endometrioid adenocarcinoma (EC).Methods: Our database of women with EC was quired for patients with stage II EC. Pathologic slides were retrieved and reviewed by gynecologic pathologists to determine cervical stromal thickness and depth of CSI as a percentage of stromal thickness (%CSI). Kaplan-Meier, univariate, and multivariate analyses were used to compare recurrence-free, disease-specific (DSS), and overall survival (OS) between women who had<50% versus = 50% CSI. Univariate and multivariate analyses were used to assess other prognostic variables associated with survival endpoints.Results: A total of 117 patients were included in our study who had hysterectomy between 1/1990 and 8/2021. Seventy-nine patients (68%) with <50% and 38 (32w%) with = 50% CSI. After a median follow-up of 131 months, 5-year DSS was significantly worse for women with = 50% CSI (78% vs. 91%; P=0.04). However, %CSI was not an independent predictor for any of the studied survival endpoints. Independent predictors of worse 5-year recurrence-free survival and DSS included FIGO grade 3 tumors (P=0.02) and the presence of lymphovascular space invasion (P=0.03). Grade 3 tumors were the only independent predictor of worse 5-year OS (P=0.02).Conclusions: Our results suggest that deep CSI is not an independent prognostic factor for survival endpoints in women with stage II uterine endometroid adenocarcinoma. The lack of independent prognostic significance of the depth CSI needs to be validated in a multi-institutional analysis.
引用
收藏
页码:445 / 449
页数:5
相关论文
共 50 条
  • [1] Recurrence patterns and survival endpoints in women with stage II uterine endometrioid carcinoma: A multi-institution study
    Elshaikh, Mohamed A.
    Al-Wahab, Zaid
    Mahdi, Haider
    Albuquerque, Kevin
    Mahan, Meredith
    Kehoe, Siobhan M.
    Ali-Fehmi, Rouba
    Rose, Peter G.
    Munkarah, Adnan R.
    GYNECOLOGIC ONCOLOGY, 2015, 136 (02) : 235 - 239
  • [2] The prognostic impact of substantial lymphovascular space invasion in women with node negative FIGO stage I uterine carcinoma
    Bhatnagar, Aseem Rai
    Ghanem, Ahmed I.
    Alkamachi, Bassam
    Allo, Ghassan
    Lin, Chun -Hui
    Hijaz, Miriana
    Elshaikh, Mohamed A.
    GYNECOLOGIC ONCOLOGY, 2024, 188 : 44 - 51
  • [3] The impact of adjuvant vaginal brachytherapy in women with Stage II uterine endometrioid carcinoma: Results of a National Cancer Database analysis
    Lee, Joon K.
    Ghanem, Ahmed I.
    Modh, Ankit
    Burmeister, Charlotte
    Mahmoud, Omar
    Maxwell, G. Larry
    Elshaikh, Mohamed A.
    BRACHYTHERAPY, 2018, 17 (02) : 319 - 325
  • [4] Juxtatumoral Stromal Reactions in Uterine Endometrioid Adenocarcinoma and Their Prognostic Significance
    Wei, Shi
    Conner, Michael G.
    Zhang, Kui
    Siegal, Gene P.
    Novak, Lea
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2010, 29 (06) : 562 - 567
  • [5] Quantification of recurrence risk based on number of adverse prognostic factors in women with stage I uterine endometrioid carcinoma
    Cook, Andrew E.
    Aref, Ibrahim
    Burmeister, Charlotte
    Hijaz, Miriana
    Elshaikh, Mohamed A.
    JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION, 2021, 22 (04) : 262 - 267
  • [6] Prognostic significance of DNA cytometry in carcinoma of the uterine cervix FIGO stage IB and II
    Grote, HJ
    Friedrichs, N
    Pomjanski, N
    Guhde, HF
    Reich, O
    Böcking, A
    ANALYTICAL CELLULAR PATHOLOGY, 2001, 23 (3-4): : 97 - 105
  • [7] Recurrence Risk Stratification for Women With FIGO Stage I Uterine Endometrioid Carcinoma Who Underwent Surgical Lymph Node Evaluation
    Ghanem, Ahmed I.
    Bhatnagar, Aseem
    Elshaikh, Muneer
    Hijaz, Miriana
    Elshaikh, Mohamed A.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2023, 46 (12): : 537 - 542
  • [8] Obesity and Lymphovascular Invasion in Women with Uterine Endometrioid Carcinoma
    Kamal, Mona
    Burmeister, Charlotte
    Zhang, Ziying
    Munkarah, Adnan
    Elshaikh, Mohamed A.
    ANTICANCER RESEARCH, 2015, 35 (07) : 4053 - 4057
  • [9] Stage II endometrioid adenocarcinoma of the endometrium: Clinical implications of cervical stromal invasion
    Orezzoli, Jorge P.
    Sioletic, Stefano
    Olawaiye, Alexander
    Oliva, Esther
    del Carmen, Marcela G.
    GYNECOLOGIC ONCOLOGY, 2009, 113 (03) : 316 - 323
  • [10] Survival endpoints for young women with early stage uterine endometrioid carcinoma: a matched analysis
    Isrow, Derek
    Burmeister, Charlotte
    Hanna, Rabbie K.
    Elshaikh, Mohamed A.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2016, 207 : 115 - 120